Hyaluronidase inhibitors: A biological and therapeutic perspective

Current Medicinal Chemistry

Volumn 16, Issue 18, 2009, Pages 2261-2288

  Girish, K S ^a   Kemparaju, K ^a   Nagaraju, S ^a   Vishwanath, B S ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Animal venoms; Bioactive molecules; Extracellular matrix; Flavonoids; Hyaluronan; Hyaluronidase inhibitors; Microbial venoms; Synthetic molecules

Indexed keywords

ALKALOID; ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ANTIPARASITIC AGENT; ASCORBIC ACID; BENZIMIDAZOLE; BENZOXAZOLE 2 THIONE; BETA GLUCURONIDASE; BETA N ACETYLHEXOSAMINIDASE; CC 517; COTRIMOXAZOLE; FATTY ACID; FLAVONOID; GLYCOSIDASE INHIBITOR; HYALURONIC ACID; HYALURONIDASE; HYALURONIDASE ANTIBODY; INDOMETACIN; IVERMECTIN; LANOSTANOID DERIVATIVE; LEPIDEYPYRONE; LINCO SPECTIN; PH 20; PLANT EXTRACT; POLYSACCHARIDE; TANNIN; TERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ENZYME INHIBITOR; HYALURONOGLUCOSAMINIDASE;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; BINDING SITE; CARBOHYDRATE METABOLISM; CELL MEMBRANE; DNA SEQUENCE; DRUG MECHANISM; DRUG SENSITIVITY; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; HYDROLYSIS; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MEDICINAL PLANT; MOLECULAR WEIGHT; NONHUMAN; OXIDATIVE STRESS; PERMEABILITY; REVIEW; SEQUENCE HOMOLOGY; SURVIVAL TIME; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; METABOLISM; PHYSIOLOGY;

ANIMALS; DRUG DESIGN; ENZYME INHIBITORS; HOMEOSTASIS; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MODELS, MOLECULAR; MOLECULAR STRUCTURE;

EID: 67949124763     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788453078     Document Type: Review

References (198)

1. Laurent, T.C.; Fraser J.R. Hyaluronan. FASEB J., 1992, 6, 2397-04.
2. Spicer, A.P.; McDonald, J.A. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J. Biol. Chem., 1998, 273, 1923-32.
3. Lee, J.Y.; Spicer, A.P. Hyaluronan: A multifunctional, megadalton, stealth molecule. Curr. Opin. Cell Biol., 2000, 12, 581-86.
4. Toole, B.P. Hyaluronan: From extracellular glue to pericellular cue. Nat. Rev. Can., 2004, 4, 528-39.
5. Girish, K.S.; Kemparaju, K. The magic glue hyaluronan and its eraser hyaluronidase: A biological overview. Life Sci., 2007, 80, 1921-43.
6. Meyer, K.; Palmer, J.W. The polysaccharide of the vitreous humor. J. Biol. Chem., 1934, 107, 629-34.
7. Weissman, B.; Meyer, K.J. The structure of hyalobiuronic acid and hyaluronic acid from umbilical cord. J. Am. Chem. Soc., 1954, 76, 1753-57.
8. Matsushita, O.; Okabe, A. Clostridial hydrolytic enzymes degrading extracellular components. Toxicon 2001, 39, 1769-80.
9. Weigel, P.H.; Hascall, V.C.; Tammi, M. Hyaluronan synthases. J. Biol. Chem., 1997, 272, 13997-00.
10. Itano, N.; Sawai, T.; Yoshida, M.; Lenas, P.; Yamada, Y.; Imagawa, M.; Shinomura, T.; Hamaguchi, M.; Yoshida, Y.; Ohnuki, Y.; Miyauchi, S.; Spicer, A.P.; McDonald, J.A.; Kimata, K. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem., 1999, 274, 25085-92.
11. Adamia, S.; Maxwell, C.A.; Pilarski, L.M. Hyaluronan and hyaluronan synthases: Potential therapeutic target in cancer. Curr. Drug Targets (Cardiovas. Haematol. Dis.), 2005, 5, 3-14.
12. Spicer, A.P.; Joo, A.; Bowling Jr, R.A. A hyaluronan binding link protein gene family whose members are physically linked adjacent to chondroitin sulfate proteoglycan core proteins genes: The missing links. J. Biol. Chem., 2003, 278, 21083-91.
13. Day, A.J.; Prestwich, G.D. Hyaluronan-binding proteins: Tying up the giant. J. Biol. Chem., 2002, 277, 4585-88.
14. Knudson, C.B.; Knudson, W. 2004. Hyaluronan and CD44: Modulators of chondrocyte metabolism. Clin. Ortho. Rela. Res., 2004, 427S, S152-S62.
15. Noble, P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol., 2002, 21, 25-29.
16. Stern, R.; Asari, A.A.; Sugahara, K.N. Hyaluronan fragments: An information-rich system. Eur. J. Cell Biol., 2006, 85, 699-715.
17. Termeer, C.; Benedix, F.; Sleeman, J.; Fieber, C.; Voith, U.; Ahrens, T.; Miyake, K.; Freudenberg, M.; Galanos, C.; Simon, J.C. 2002. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med., 2002, 195, 99-111.
18. Rossler, A.; Hinghofer-Szalkay, H. Hyaluronan fragments: An information carrying system? Horm. Metabol. Res., 2002, 35, 67-68.
19. Stern, R. Devising a pathway for hyaluronan catabolism: Are we there yet? Glycobiology, 2003, 13, 105R-15R.
20. Murai, T.; Miyazaki, Y.; Nishinakamura, H.; Sugahara, K.N.; Miyauchi, T.; Sako, Y.; Yanagida, T.; Miyasaka, M. Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J. Biol. Chem., 2004, 279, 4541-50.
21. Taylor, K.R.; Trowbridge, J.M.; Rudisill, J.A.; Termeer, C.C.; Simon, J.C.; Gallo, R.L. 2004. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem., 2004, 279, 17079-84.
22. Jiang, D.; Liang, J.; Fan, J.; Yu, S.; Chen, S.; Luo, Y.; Prestwich, G.D.; Mascarenhas, M.M.; Garg, H.G.; Quinn, D.A.; Homer, R.J.; Goldstein, D.R.; Bucala, R.; Lee, P.J.; Medzhitov, R.; Noble, P.W. 2005. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med., 2005, 11, 1173-79.
23. McKee, C.M.; Penno, M.B.; Cowman, M.; Burdick, M.D.; Strieter, R.M.; Bao, C.; Noble, P.W. Hyaluronan fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest., 1996, 15, 2403-13.
24. Iacob, S.; Knudson, C.B. 2006. Hyaluronan fragments activate nitric oxide synthase and the production of nitric oxide by articular chondrocytes. Int. J. Biochem. Cell. Biol., 2006, 38, 123-33.
25. Chen, W.J.Y.; Abatangelo, G. Functions of hyaluronan in wound repair. Wound Repair Regen., 1999, 7, 79-89.
26. Day, A.J.; de la Motte, C.A. Hyaluronan cross-linking: A protective mechanism in inflammation. Trend. Immunol., 2005, 26, 637-43.
27. Milner, C.M.; Higman, V.A.; Day, A.J. TSG-6: A pluripotent inflammatory mediator? Biochem. Soc. Trans., 2006, 34, 446-50
28. Laurent, T.C.; Fraser, J.R. The properties and turnover of hyaluronan. CIBA Found Sym., 1986, 124, 9-29.
29. Tammi, M.I., Tammi, R. Hyaluronan in the Epidermis. http://www.glycoforum.gr.jp/science/hyaluronan/hyaluronanE.html.
30. Duran-Reynals, F. Exaltation de l'activité du virus vaccinal par les extraits de certains organs. C. R. Soc. Biol., 1928, 99, 6-7.
31. Hoffman, D.C.; Duran-Reynals, F. The influence of testicular exytract on the intradermal spread of injected fluids and particles. J. Exp. Med., 1931, 53, 387-98.
32. Duran-Reynals, F. Studies on a certain spreading factor existing in bacteria and its significance for bacterial invasiveness. J. Exp. Med., 1931, 58, 161-81.
33. Meyer, K. Hyaluronidases. In: Boyer P.D. Ed.; Academic Press, New york, 1971; pp. 307-20.
34. Roden, L.; Campbell, P.; Fraser, J.R.; Laurent, T.C.; Pertoft, H.; Thompson, J.N. Enzymatic pathways of hyaluronan catabolism. CIBA. Found. Sym., 1989, 143, 60-86.
35. Frost, G.I.; Csoka, T.; Stern, R. The hyaluronidases: A chemical, biological and clinical overview. Trend. Glycosci. Glycotech., 1996, 8, 419-34.
36. Csoka, A.B.; Frost, G.I.; Stern, R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol., 2001, 20, 499-508.
37. Jedrzejas, M.J.; Stern, R. Structures of vertebrate hyaluronidases and their unique enzymatic mechanism of hydrolysis. Proteins (Str Fun Bioinform) 2005, 61, 227-38.
38. Stern, R.; Jedrzejas, M.J. Hyaluronidases: Their genomics, structures, and mechanisms of action. Chem. Rev., 2006, 106, 818-39.
39. Chao, K.L.; Muthukumar, L.; Herzberg, O. Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis. Biochemistry, 2007, 46, 6911-20.
40. Lokeshwar, V.B.; Obek, C.; Pham, H.T.; Wei, D.; Young, M.J.; Duncan, R.C.; Soloway, M.S.; Block, N.L. Urinary hyaluronic acid and hyaluronidase: Markers for bladder cancer detection and evaluation of grade. J. Urol., 2000, 163, 348-56.
41. Lokeshwar, V.B.; Schroeder, G.L.; Carey, R.I.; Soloway, M.S.; Iida, N. Regulation of hyaluronidase activity by alternative mRNA splicing. J. Biol. Chem., 2002, 277, 33654-63.
42. Lokeshwar, V.B.; Selzer, M.G. Hyaluronidase: Both a tumor promoter and suppressor. Semin. Cancer Biol., 2008, 18, 281-87
43. Stern, R. Hyaluronidases in cancer biology. Semin. Cancer Biol., 2008, 18, 275-80.
44. Lokeshwar, V.B.; Cerwinka, W.H.; Lokeshwar, B.L. HYAL1 hyaluronidase: A molecular determinant of bladder tumor growth and invasion. Cancer Res., 2005, 65, 2243-50.
45. Triggs-Raine, B; Salo, T.J.; Zhang, H.; Wicklow, B.A.; Natowicz, M.R. Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX. Proc. Natl. Acad. Sci. USA, 1999, 96, 6296-6300.
46. Martin, D.C.; Atmuri, V.; Hemming, R.J.; Farley, J.; Mort, J.S.; Byers, S.; Hombach-klonisch, S.; Stern, R.; Triggs-Raine, B.L. A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis. Hum. Mol. Gen., 2008, 17, 1904-15.
47. Lepperdinger, G.; Mullegger, J.; Kreil, G. HYAL2-less active, but more versatile? Matrix Biol., 2001, 20, 509-14.
48. Rai, S.K.; Duh, F.M.; Vigdorovich, V.; Danilkovitch-Miagkova, A.; Lerman, M. I.; and Miller, A.D. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation, Proc. Natl. Acad. Sci. USA, 2001, 98, 4443-48.
49. Lepperdinger, G.; Strobl, B.; Kreil, G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J. Biol. Chem., 1998, 273, 22466-70
50. Vines, C.A.; Li, M.W.; Deng, X.; Yudin, A.I.; Cherr, G.N.; Overstreet, J.W. Identification of a hyaluronic acid (HA) binding domain in the PH-20 protein that may function in cell signaling. Mol. Reprod. Dev., 2001, 60, 542-52.
51. Franzmann, E.J.; Schroeder, G.L.; Goodwin, W.J.; Weed, D.T.; Fisher, P.; Lokeshwar, V.B. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int. J. Cancer, 2003, 106, 438-45.
52. Cherr, G.N.; Yudin, A.I.; Overstreet, J.W. The dual functions of GPIanchored PH-20: Hyaluronidase and intracellular signaling. Matrix Biol., 2001, 20, 515-25.
53. Flannery, C.R.; Little, C.B.; Hughes, C.E.; Caterson, B. Expression and activity of articular cartilage hyaluronidases. Biochem. Biophys. Res. Com., 1998, 252, 824-29.
54. Nicoll, S.B.; Barak, O.; Csoka, A.B.; Bhatnagar, R.S.; Stern, R. Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. Biochem. Biophys. Res. Com., 2002, 292, 819-25.
55. Atmuri, V.; Martin, D.C.; Hemming, R.; Gutsol, A.; Byers, S.; Sahebjam, S.; Thliveris, J.A.; Mort, J.S.; Carmona, E.; Anderson, J.E.; Dakshinamurthi, S.; Triggs-Raine, B. Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation. Matrix Biol., 2008, 27(8), 653-60.
56. Xu, X.; Wang, X.; Xi, X.; Liu, J.; Huang, J.; Lu, Z. Purification and partial characterization of hyaluronidase from five pace snake ( Agkistrodon acutus) venom. Toxicon, 1982, 20, 973-81.
57. Kudo, K.; Tu, A.T. Characterization of hyaluronidase isolated from Agkistrodon contortrix contortrix (Southern Copperhead) venom. Arch. Biochem. Biophys., 2001, 386, 154-62.
58. Girish, K.S.; Shashidhara murthy, R.; Nagaraju, S.; Gowda, T.V.; Kemparaju, K. Isolation and characterization of hyaluronidase a "spreading factor" from Indian cobra (Naja naja) venom. Biochimie, 2004, 86, 193-202.
59. Girish, K.S.; Kemparaju, K. A low molecular weight isoform of hyaluronidase: Purification from Indian cobra (Naja naja) venom and partial characterization. Biochemistry (Mos) 2005, 70, 708-12.
60. Kemparaju, K.; Girish, K.S. Snake venom hyaluronidase: A therapeutic target. Cell Biochem. Fun., 2006, 24, 7-12.
61. Ramanaiah, M.; Parthasarathy P.R.; Venkaiah, B. Isolation and characterization of hyaluronidase from scorpion (Heterometrus fulvipus) venom. Biochem. Int., 1990, 20, 301-310.
62. Pessini, A.C.; Takao, T.T.; Cavalheiro, E.C.; Vichnewski, W.; Sampaio, S.V.; Giglio, J.R.; Arantes, E.C. A hyaluronidase from Tityus serrulatus scorpion venom isolation characterization and inhibition by flavonoids. Toxicon, 2001, 39, 1495-504.
63. Morey, S.S.; Kiran, K.M.; Gadag, J.R. Purification and properties of hyaluronidase from Palamneus gravimanus (Indian black scorpion) venom. Toxicon, 2006, 47, 188-95.
64. Feng. L.; Gao, R.; Gopalakrishnakone, P. Isolation and characterization of a hyaluronidase from the venom of Chinese red scorpion Buthus martensi. Comp. Biochem. Physiol., (Part C) 2008, 148, 250-57.
65. Gmachl, M.; Kreil, G. Bee venom hyaluronidase is homologous to a membrane protein of mammalian sperm. Proc. Natl. Acad. Sci. USA, 1993, 90, 3569-73.
66. Markovic-Housley, Z.; Miglierini, G.; Soldatova, L.; Rizkallah, P.J.; Muller, U.; Schirmer, T. Crystal structure of hyaluronidase, a major allergen of bee venom. Structure, 2000, 8, 1025-35.
67. Kreil, G. 1995. Hyaluronidases-a group of neglected enzymes. Protein Sci. 1995, 4, 1666-69.
68. Lu, G.; Kochoumian, L.; King, T.P. Sequence identity and antigenic cross reactivity of white face hornet venom allergen, also a hyaluronidase, with other proteins. J. Biol. Chem., 1995, 270, 4457-65.
69. Rash, L.D.; Hodgson, W.C. Pharmacology and biochemistry of spider venoms. Toxicon, 2002, 40, 225-54.
70. Nagaraju, S.; Mahadeshwaraswamy, Y.H.; Girish, K.S.; Kemparaju, K Biochemical and pharmacological characterization of venom from the spiders H. partita, H. aglenoides and H. mahabaleshwarensis tikadar and malhotra. Comp. Biochem. Physiol., (Part C) 2006, 149, 1-9.
71. da C B Gouveia, A.I.; da Silveira, R.B.; Nader, H.B.; Dietrich, C.P.; Gremski, W.; Veiga, S.S. Identification and partial characterisation of hyaluronidases in Lonomia obliqua venom. Toxicon, 2005, 45, 403-10.
72. Poh, C.H.; Yuen, R.; Chung, M.C.M.; Khoo, H.E. Purification and partial characterization of hyaluronidase from stonefish (Synanceja horrida) venom. Comp. Biochem. Physiol., (Part B) 1992, 101 , 159-63.
73. Ng, H.C.; Ranganathan, S.; Chua, K.L.; Khoo, H.E. Cloning and molecular characterization of the first aquatic hyaluronidase, SFHYA1, from the venom of stonefish (Synanceja horrida). Gene 2005, 346, 71-81.
74. Magalhaes, M.R.; da Silva N.J. Jr; Ulhoa, C.J. A hyaluronidase from Potsmotrygon motoro (Freshwater stingrays) venom: Isolation and characterization. Toxicon, 2008, 51, 1060-67.
75. Tu, A.T.; Hendon, R.R. Characterization of lizard venom hyaluronidase and evidence for its action as a spreading factor. Comp. Biochem. Physiol., (Part B) 1983, 76, 377-83.
76. Kolarich, D.; Leonard, R.; Hemmer, W.; Altmann, F. The N-glycans of yellow jacket venom hyaluronidases and the protein sequence of its isoform in Vespula vulgaris. FEEBS J. 2005, 272, 5182-90.
77. Volfova, V.; Hostomska, J.; Cerny, M.; Votypka, J.; Volf, P. Hyaluronidase of bloodsucking insects and its enhancing effect on Leishmania infection in mice. PloS Negl. Trop. Dis., 2008, 2, e294.
78. Sutherland, I.W. Polysaccharide lyases. FEMS Microbiol. Rev., 1995, 16, 323-47.
79. Jedrzejas, M.J. Pneumococcal virulence factors: Structure and function. Microbiol. Mol. Biol. Rev., 2001, 65, 187-207.
80. Jedrzejas, M.J. Extracellular virulence factors of Streptococcus pneumoniae. Front. Biosci., 2004, 9, 891-14.
81. Makris, G.; Wright, J.D.; Ingham, E.I.; Holland, K.T. The hyaluronate lyase of Staphylococcus aureus-a virulence factor? Microbiology, 2004, 150, 2005-13.
82. Hynes, W.L.; Walton, S.L. Hyaluronidases of Gram-positive bacteria. FEMS Microbiol. Lett., 2000, 183, 201-07.
83. Spellerberg, B. Pathogenesis of neonatal Streptococcus agalactiae infections. Microbe Infect., 2000, 2, 1733-42.
84. Fitzgerald, T.J.; Gannon, E.M. Further evidence for hyaluronidase activity of Treponema pallidum. Can. J. Microbiol., 1983, 29, 1507-13.
85. Berry, A.M.; Lock, R.A.; Thomas, S.M.; Rajan, D.P.; Hansman, D.; Paton, J.C. Cloning and nucleotide sequence of the Streptococcus pneumoniae hyaluronidase gene and purification of the enzyme from recombinant Escherichia coli. Infect. Immun., 1994, 62, 1101-08.
86. Gunther, E.; Ozegowski, J.H.; Kohler, W. Occurrence of extracellular hyaluronic acid and hyaluronate lyase in Streptococci of groups A, B, C, and G. Zentralblatt fur Bakteriologie 1996, 285, 64-73.
87. Linhardt, R.J.; Galliher, P.M.; Cooney, C.L. Polysaccharide lyases. App. Microbiol. Biotech., 1986, 12, 135-76.
88. Sting, R.; Schaufuss, P.; Blobel, H. Isolation and characteri-zation of hyaluronidases from Streptococcus dysgalactiae, S. zooepidemicus and S. equi. Zentralblatt fur Bakteriologie, 1990, 272, 276-82.
89. Kostyukova, N.N.; Volkova, M.O.; Ivanova, V.V.; Kvetnaya, A.S. A study of pathogenic factors of Streptococcus pneumoniae strains causing meningitis. FEMS Immun. Med. Microbiol., 1995, 10, 133-37.
90. Li, S.; Kelly, S.J.; Lamani, E.; Ferraroni, M.; Jedrzejas, M.J. Structural basis of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. EMBO J. 2000, 19, 1228-40.
91. Shimizu, M.T.; Jorge, A.O.C.; Unterkircher, C.S.; Fantinato, V.; Paula, C.R. Hyaluronidse and chondroitin sulphatase production by different species of Candida. J. Med. Vet. Mycol., 1995, 33, 27-31.
92. de Assis, C.M.; Gandra, R.F.; Gambale, W.; Shimizu, M.T.; Paula, C.R. Biosynthesis of chondroitinase and hyaluronidase by different strains of Paracoccidioides brasiliensis. J. Med. Microbiol., 2003, 52, 479-81.
93. Arming, S.; Strobl, B.; Wechselberger, C.; Kreil, G. In vitro mutagenesis of PH-20 hyaluronidase from human sperm. Eur. J. Biochem., 1997, 247, 810-814.
94. Oettl, M.; Hoechstetter, J.; Asen, I.; Bernhardt, G.; Buschauer, A. Comparative characterization of bovine testicular hyaluronidase and a hyaluronate lyase from Streptococcus agalactiae in pharmaceutical preparations. Eur. J. Pharama. Sci., 2003, 18, 267-277.
95. Harrison, R.A.; Ibison, F.; Wilbraham, D.; Wagstaff, S.C. Identification of cDNAs encoding viper venom hyaluronidases: Cross generic sequence conservation of full length and unusually short variant transcripts. Gene 2007, (In press).
96. Rigden, D.J.; Jedrzejas, M.J.; deMello, L.V. Identification and analysis of catalytic TIM barrel domains in seven further glycoside hydrolase families. FEBS Lett., 2003, 544, 103-111.
97. Jedrzejas, M.J. Structural and functional comparison of polysaccharide degrading enzymes. Crit. Rev. Biochem. Mol. Biol., 2000, 35, 221-251.
98. Jedrzejas, M.J. Pneumococcal virulence factors: Structure and function. Microbiol. Mol. Biol. Rev., 2001, 65, 187-207.
99. Stern, R. Hyaluronan in cancer biology. Semin. Cancer Biol., 2008, 18, 237.
100. Haas, E. On the mechanism of invasion. I. Antinvasin I, An enzyme in plasma. J. Biol. Chem., 1946, 164, 63-88.
101. Grais, M.L.; Glick, D. Mucolytic enzyme systems. II Inhibition of hyaluronidase by serum in skin diseases. J. Clin. Dermatol., 1948, 11, 259-73.
102. Snively, G.G.; Glick, D. Mucolytic enzyme systems. X. Serum hyaluronidase inhibitor in liver disease. J. Clin. Invest., 1950, 29, 1087-90.
103. Newman, J.K.; Berenson, G.S.; Mathews, M.B.; Goldwasser, E.; Dorfman, A. The isolation of the non-specific hyaluronidase inhibitor of human blood. J. Biol. Chem., 1955, 217, 31-41.
104. Kolarova, M. Host-tumor relationship XXXIII. Inhibitor of hyaluronidase in blood serum of cancer patients. Neoplasma, 1975, 22, 435-39.
105. Mio, K.; Carrette, O.; Maibach, H.I.; Stern, R. Evidence that the serum inhibitor of hyaluronidase may be a member of the inter-alpha-inhibitor family J. Biol. Chem., 2000, 275, 32413-21.
106. Machiah, K.D.; Girish, K.S.; Gowda, T.V. A glycoprotein from a folk medicinal plant, Withania somnifera, inhibits hyaluronidase activity of snake venoms. Comp. Biochem. Physiol., (Part C) 2006, 143, 158-61.
107. 2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera. Biochimie 2006, 88, 701-10.
108. Wolf, R.A.; Glogar, D.; Chaung, L.Y.; Garrett, P.E.; Ertl, G.; Tumas, J.; Braunwald, E.; Kloner, R.A.; Feldstein, M.L.; Muller, J.E. Heparin inhibits bovine testicular hyaluronidase activity in myocardium of dogs with coronary artery occlusion. Am. J. Cardiol., 1984, 53, 941-44.
109. Maksimenko, A.V.; Petrova, M.L.; Tischenko, E.G.; Schechilina, Y.V. Chemical modification of hyaluronidase regulates its inhibition by heparin. Eur. J. Pharma. Biopharmacol., 2001, 51, 33-38.
110. Mio, K.; Stern, R. Inhibitors of the hyaluronidases. Matrix Biol., 2002, 21, 31-37.
111. Afify, A.M.; Stern, M.; Guntenhoener, M.; Stern, R. Purification and characterization of human serum hyaluronidase. Arch. Biochem. Biophys., 1993, 305, 434-41.
112. Girish, K.S.; Kemparaju, K. Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides. Biochemistry (Mos), 2005, 70, 948-52.
113. 2 myotoxins. Toxicon, 1999, 37, 199-215.
114. Mors, W.B.; Nascimento, M.C.; Pereira, B.M.; Pereira, N.A. Plant natural products active against snake bite-the molecular approach. Phytochemistry 2000, 55, 627-42.
115. Diccianni, M.B,; Mistry, M.J.; Hug, K.; Harmony, J.A. Inhibition of Phospholipase A2 by heparin. Biochim. Biophys. Acta, 1990, 1046, 242-248.
116. Toida, T.; Ogita, Y.; Suzuki, A.; Toyoda, H.; Imanari, T. Inhibition of hyaluronidase by fully O-sulfonated glycosaminoglycans. Arch. Biochem. Biophys., 1999, 370, 233-41.
117. Salmen, S.; Hoechstetter, J.; Kasbauer, C.; Paper, D.H.; Bernhardt, G.; Buschauer, A. Sulphated oligosaccharides as inhibitors of hyaluronidases from bovine testis, bee venom and Streptococcus agalactiae. Planta Med., 2005, 71, 727-32.
118. Raghavan, D.; Simionescu, D.T.; Vyavahare, N.R. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials, 2007, 28, 2861-68.
119. Sawabe, Y.; Nakagomi, K.; Iwagami, S.; Suzuki, S.; Nakazawa, H. Inhibitory effects of pectic substances on activated hyaluronidase and histamine release from mast cells. Biochim. Biophys. Acta., (Molecular cell research) 1992, 1137, 274-78.
120. Isoyama, T.; Thwaites, D.; Selzer, M.G.; Carey, R.I.; Barbucci, R.; Lokeshwar, V.B. Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases. Glycobiology, 2006, 16, 11-21.
121. Udabage, L.; Brownlee, G.R.; Stern, R.; Brown, T.J. Inhibition of hyaluronan degradation by dextran sulphate facilitates characterization of hyaluronan synthesis: An in vitro and in vivo study. Glycoconjug. J. 2004, 20, 461-71.
122. Harish Prashanth, K.V.; Tharanathan, R.N. Depolymerized products of chitosan as potent inhibitors of tumor-induced angiogenesis. Biochim. Biophys. Acta, 2005, 1722, 22-29.
123. Kato, Y.; Onishi, H.; Machida, Y. Contribution of chitosan and its derivatives to cancer chemotherapy. In Vivo, 2005, 19, 301-10.
124. Rabea, E.I.; Badawy, M.E.; Stevens, C.V.; Smagghe, G.; Steurbaut, W. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules, 2003, 4, 1457-65.
125. Singla, A.K.; Chawla, M. Chitosan: Some pharmaceutical and biological aspects-an update. J. Pharma Pharmacol., 2001, 53, 1047-67.
126. Senel, S.; McClure, S.J. Potential applications of chitosan in veterinary medicine. Adv. Drug Deliv. Rev., 2004, 56, 1467-80.
127. Denuziere, A.; Ferrier, D.; Domard, A. Interactions between chitosan and glycosaminoglycans (chondroitin sulfate and hyaluronic acid): physicochemical and biological studies. Anns. Pharmcol. (France) 2000, 58, 47-53.
128. Asada, M.; Sugie, M.; Inoue, M.; Nakagomi, K.; Hongo, S.; Murata, K.; Irie, S.; Takeuchi, T.; Tomizuka, N.; Oka, S. Inhibitory effect of alginic acids on hyaluronidase and on histamine release from mast cells. Biosci. Biotech. Biochem., 1997, 61, 1030-32.
129. Katsube, T.; Yamasaki, Y.; Iwamoto, M.; Oka, S. Hyaluronidase-inhibiting polysaccharide isolated and purified from hot water extract of Sporophyll of Undaria pinnatifida. Food Sci. Technol. Res., 2003, 9, 25-29.
130. Zaneveld, L.J.D.; Anderson, R.A.; Diao, X-H.; Walker, D.P.; Chany II, C.; Feathergill, K.; Doncel, G.; Cooper, M.D.; Herold, B. Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis. Fertility Sterility, 2002, 78, 1107-15.
131. Suzuki, K.; Terasaki, Y.; Uyeda, M. Inhibition of hyaluronidase and chondroitinases by fatty acids. J. Enz. Inhib. Med. Chem., 2002, 17, 183-86.
132. Girish, K.S.; Kemparaju, K. Inhibition of Naja naja venom hyaluronidase: Role in the management of poisonous bite. Life Sci., 2006, 78, 1433-40.
133. Havsteen, B. Flavonoids, a class of natural products of high pharamacological potency. Biochem. Pharmacol., 1984, 32, 1141-48.
134. Middleton, E.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 2000, 52, 673-51.
135. Hollman, P.C.H.; Arts, I.C.W. Flavonols, flavones and flavanols-nature, occurrence and dietary burden. J. Sci. Food Agricul., 2000, 80, 1081-93.
136. Kuppusamy, U.; Khoo, H.; Das, N. Structure-activity studies of flavonoids as inhibitors of hyaluronidase. Biochem. Pharmacol., 1990, 40, 397-401.
137. Kuppusamy, U.R.; Das, N.P. Inhibitory effects of flavonoids on several venom hyaluronidases. Experientia, 1991, 47, 1196-2000.
138. Kuppusamy, U.R.; Das, N.P. Protective effects of tannic acid and related natural compounds on Crotalus adamenteus subcutaneous poisoning in mice. Pharmacol. Toxicol., 1993, 72, 290-95.
139. Li, M.W.; Yudin, A.I.; VandeVoort, C.A.; Sabeur, K.; Primakoff, P.; Overstreet, J.W. Inhibition of monkey sperm hyaluronidase activity and heterologous cumulus penetration by flavonoids. Biol. Reprod., 1997, 56, 1383-89.
140. Garg, A.; Anderson, R.A.; Zaneveld, L.J.; Garg, S. Biological activity assessment of a novel contraceptive antimicrobial agent. J. Androl., 2005, 26, 414-21.
141. Lee, Y.M.; Choi, S.I.; Lee, J.W.; Jung, S.M.; Park, S.M.; Heo, T.R. Isolation of hyaluronidase inhibitory component from the roots of Astragalus membranaceus Bunge (Astragali Radix). Food Sci. Biotech., 2005, 14, 263-67.
142. Choi, S.I.; Heo, T.R.; Min, B.H.; Cui, J.H.; Choi, B.H.; Park, S.R. Alleviation of osteoarthritis by calycosin-7-O-beta-D-glucopyranoside (CG) isolated from Astragali radix (AR) in rabbit osteoarthritis (OA) model. Osteoarthritis Cartilage, 2007, 15, 1086-92.
143. Salmen, S. Inhibitors of bacterial and mammalian hyaluronidases: synthesis and structure-activity relationships, Ph. D. thesis; University of Regensburg: Regensburg (Germany), 2003.
144. Furuya, T.; Yamagata, S.; Shimoyama, Y.; Fujihara, M.; Morishima, N.; Ohtsuki, K. Biochemical characterization of glycyrrhizin as an effective inhibitor for hyaluronidases from bovine testis. Biol. Pharma. Bull., 1997, 20, 973-77.
145. Hertel, W.; Peschel, G.; Ozegowski, J.H.; Muller, P.J. Inhibitory effects of Triterpenes and Flavonoids on the enzymatic activity of hyaluronic acid-splitting enzymes. Arch. Pharm. Chem. Life Sci., 2006, 339, 313-18.
146. Bravo, L. Polyphenols: Chemistry, dietary sources, metabolism and nutritional significance. Nutr. Rev., 1998, 56, 317-33.
147. Duthie, G.G.; Duthie, S.J.; Kyle, J.A.M. Plant polyphenols in cancer and heart disease: Implications as nutritional antioxidants. Nutr. Res. Rev., 2000, 13, 79-106.
148. Abell, A.D.; Ratcliffe, M.J.; Gerrard, J. Ascorbic acid-based inhibitors of alpha-amylases. Bioorg. Med. Chem. Lett., 1998, 8, 1703-06.
149. Okorukwu, O.N.; Vercruysse, K.P. Effects of ascorbic acid and analogs on the activity of testicular hyaluronidase and hyaluronan lyase on hyaluronan. J. Enz. Inhibit. Med. Chem., 2003, 18, 377-82.
150. Li, S.; Taylor, K.B.; Kelly, S.J.; Jedrzejas, M.J. Vitamin C inhibits the enzymatic activity of Streptococcus pneumoniae hyaluronate lyase. J. Biol. Chem., 2001, 276, 15125-30.
151. Botzki, A.; Rigden, D.J.; Braun, S.; Nukui, M.; Salmen, S.; Hoechstetter, J.; Bernhardt, G.; Dove, S.; Jedrzejas, M.J.; Buschauer, A. L-Ascorbic acid, 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes. J. Biol. Chem., 2004, 279, 45990-97.
152. Scott, J.E. Secondary structures in hyaluronan solutions: Chemical and biological implications. Ciba. Found. Symp., 1989, 143, 6-15.
153. Spickenreither, M.; Braun, S.; Bernhardt, G.; Dove, S.; Buschauer, A. Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases. Bioorg. Med. Chem. Lett., 2006, 16, 5313-16.
154. Hofinger, E.S.A.; Spickenreither, M.; Oschmann, J.; Bernhardt, G.; Rudolph, R.; Buschauer, A. Recombinant human hyaluronidase Hyal-1: insect cells versus Escherichia coli as expression system and identification of low molecular weight inhibitors. Glycobiology, 2007, 17, 444-53.
155. Tatemoto, T.; Tokeshi, I.; Nakamura, S.; Muto, N.; Nakada, T. Inhibition of boar sperm hyaluronidase activity by tannic acid reduces polyspermy during in vitro fertilization of porcine oocytes. Zygote, 2006, 14, 275-85.
156. Tokeshi, I.; Yoshimoto, T.; Muto, N.; Nakamura, S.; Ashizawa, K.; Nakada, T.; Tatemoto, H. Antihyaluronidase action of ellagic acid effectively prevents polyspermy as a result of suppression of the acrosome reaction induced by sperm-zona interaction during in vitro fertilization of porcine oocytes. J. Reprod. Dev., 2007 , 53, 755-64.
157. Shibata, T.; Fujimoto, K.; Nagayama, K.; Yamaguchi, K.; Nakamura, T. Inhibitory activity of brown algal phlorotannins against hyaluronidase. Int. J. Food Sci. Tech., 2002, 37, 703-09.
158. Ihara, N.; Schmitz, S.; Kurisawa, M.; Chung, J.E.; Uyama, H.; Kobayashi, S. Amplification of inhibitory activity of catechin against disease-related enzymes by conjugation on poly (E-lysine). Biomacromolecules, 2004, 5, 1633-36.
159. Suleyman, H.; Demircan, B.; Karagoz, Y.; Oztasan, N.; Suleyman, B. Anti-inflammatory effects of selective COX-2 inhibitors. Polish J. Pharmacol., 2004, 56, 775-80.
160. Kakegawa, H.; Matsumoto, H.; Satoh, T. Inhibitory effects of hydrangenol derivatives on the activation of hyaluronidase and their antiallergic activities. Planta Med., 1988, 54, 385-89.
161. Kakegawa, H.; Matsumoto, H.; Satoh, T. Inhibitory effects of some natural products on the activation of hyaluronidase and their antiallergic actions. Chem. Pharm. Bull., 1992, 40, 1439-42.
162. Facino, R.; Carini, M.; Stefani, R.; Aldini, G.; Saibene, L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenis from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: Factors contributing to their efficacy in the treatment of venous insufficiency. Arch. Pharm., 1995, 328, 720-24.
163. Yingprasertchai, S.; Bunyasrisawat, S.; Ratanabanangkoon, K. Hyaluronidase inhibitors (sodium cromoglycate and sodium aurothiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma venoms. Toxicon, 2003, 42, 635-46.
164. Kakegawa, H.; Mitsuo, N.; Matsumoto, H.; Satoh, T.; Akagi, M.; Tasaka, K. Hyaluronidase-inhibitory and anti-allergic activities of the photo-irradiated products of tranilast. Chem. Pharma. Bull., (Tokyo) 1985, 33, 3738-44.
165. Tanyildizi, S.; Bozkurt, T. An investigation of the effects of ivermectin on blood serum, semen hyaluronidase activities and spermatological characteristics in sheep. Turk. J. Vet. Anim. Sci., 2002, 26, 353-57.
166. Tanyildizi, S.; Bozkurt, T. The effects of lincomycin-spectinomycin and sulfamethoxazole-trimethoprim on hyaluronidase activities and sperm characteristics of rams. J. Vet. Med. Sci., 2003, 65, 775-80.
167. Wangun, H.V.K.; Berg, A.; Hertel, W.; Nkengfack, A.E.; Hertweck, C. Anti-inflammatory and Anti-hyaluronate Lyase activities of Lanostanoids from Piptoporus betulinus. J. Antibiotics 2004, 57, 755-58.
168. Botzki, A.; Salmen, S.; Bernhardt, G.; Buschauer, A.; Dove, S. Structure-based design of bacterial hyaluronan lyase inhibitors. QSAR Comb. Sci., 2005, 24, 458-69.
169. Botzki, A. Structure-based design of hyaluronidase inhibitors, Ph. D. thesis; University of Regensburg: Regensburg (Germany), 2004.
170. Braun, S. New Inhibitors of Bacterial Hyaluronidases- Synthesis and Structure-Activity Relationships. University of Regensburg Press, Regensburg, (Germany), 2005.
171. Rigden, D.J.; Botzki, A.; Nukui, M.; Mewbourne, R.B.; Lamani, E.; Braun, S.; von Angerer, E.; Bernhardt, G.; Dove, S.; Buschauer, A.; Jedrzejas, M.J. Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: Structure of a complex with a 2-phenylindole. Glycobiology, 2006, 16, 757-65.
172. Olgen, S.; Kaeßler, A.; Nebioglu, D.; Jose, J. New potent indole derivatives as hyaluronidase inhibitors. Chem. Biol. Drug. Des., 2007, 70, 547-51.
173. Algul, O.; Kaessler, A.; Apcin, Y.; Yilmaz, A.; Jose, J. Comparative studies on conventional and microwave synthesis of some benzimidazole, benzothiazole and indole derivatives and testing on inhibition of hyaluronidase. Molecules, 2008, 13, 736-48.
174. Kaessler, A.; Nourrisson, M.R.; Duflos, M.; Jose, J. Indole carboxamides inhibit bovine testes hyaluronidase at pH 7.0 and indole acetamides activate the enzyme at pH 3.5 by different mechanisms. J. Enzyme. Inhib. Med. Chem., 2008, 23, 719-727.
175. Suleyman, H.; Gul, H.I.; Asoglu, M. Anti-inflammatory activity of 3-benzoyl-1-methyl-4-phenyl-4-piperidinol hydrochloride. Pharma. Res., 2003, 47, 471-75.
176. 2 and hyaluronidase enzymes. Bioorg. Med. Chem. Lett., 2005, 15, 4100-04.
177. Fujitani, N.; Sakaki, S.; Yamaguchi, Y.; Takenaka, H. Inhibitory effects of microalgae on the activation of hyaluronidase. J. App. Phycol., 2001, 13, 489-92.
178. Akhtar, M.S.; Bhakuni, V. Streptococcus pneumoniae hyaluronate lyase contains two non-cooperative independent folding/unfolding structural domains: Characterization of functional domain and inhibitors of enzyme. J. Biol. Chem., 2003, 278, 25509-16.
179. Hosoe, T.; Sakai, H.; Ichikawa, M.; Itabashi, T.; Ishizaki, T.; Kawai, K. Lepidepyrone, a new γ-pyrone derivative, from Neolentinus lepideus, inhibits hyaluronidase. J. Antibiotics, 2007, 60, 388-90.
180. Tanyildizi, S.; Bozkurt, T. In vitro effects of linamarin, amygdalin and gossypol acetic acid on hyaluronidase activity, sperm motility and morphological abnormality in bull sperm. Turk. J. Vet. Anim. Sci., 2004, 28, 819-24.
181. Soares, A.M.; Ticli, F.K.; Marcussi, S.; Lourenço, M.V.; Januário, A.H.; Sampaio, S.V.; Giglio, J.R.; Lomonte, B.; Pereira, P.S. Medicinal plants with inhibitory properties against snake venoms Cur. Med. Chem., 2005, 12, 2625-2641.
182. Ushanandini, S.; Nagaraju, S.; Harish kumar, K.; Vedavathi, M.; Deepa, K.M.; Kemparaju, K.; Vishwanath, B.S.; Gowda, T.V.; Girish, K.S. The anti snake venom properties of Tamarindus indica (Leguminosae) seed extract. Phytother. Res., 2006, 20, 851-858
183. Maffei Facino, R.; Carini, M.; Stefani, R.; Aldini, G.; Saibene, L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix. Arch. der. Pharmazie, 1995, 328, 720-24.
184. Lee, K.K.; Kim, J.H.; Cho, J.J.; Choi, J.D. Inhibitory effects of 150 plant extracts on elastase activity, and their anti-inflammatory effects. Int. J. Cosmetic Sci., 1999, 21, 71-82
185. Lee. K.K.; Cho, J.J.; Park, E.J.; Choi, J.D. Anti-elastase and anti-hyaluronidase of phenolic substance from Areca catechu as a new anti-ageing agent. Int. J. Cosmetic Sci., 2001, 23, 341-46.
186. Jeong, S.J.; Ahn, N.H.; Kim, Y.C.; Inagaki, M.; Miyamoto, T.; Higuchi, R. Norlignans with hyaluronidase inhibitory activity from anemarrhena asphodeloides. Planta Med., 1999, 65(4), 367-368.
187. Marquina, M.A.; Corao, G.M.; Araujo, L.; Buitrago, D.; Sosa, M. Hyaluronidase inhibitory activity from the polyphenols in the fruit of blackberry (Rubus fruticosus B). Fitoterapia, 2002, 73, 727-29.
188. Girish, K.S.; Mohankumari, H.P.; Nagaraju, S.; Vishwanath, B.S.; Kemparaju, K. Hyaluronidase and protease activities from Indian snake venoms: Neutralization by Mimosa Pudica root extract. Fitoterapia, 2004, 75, 378-90.
189. Choi, S.I.; Park, S.R.; Heo, T.R. Matrix degradation inhibitory effect of Schisandra fructus on human articular cartilage and chondrocytes. J. Ethnopharma, 2006, 106, 279-84.
190. Sumantran, V.N.; Kulkarni, A.A.; Harsulkar, A.; Wele, A.; Koppikar, S.J.; Chandwaskar, R.; Gaire, V.; Dalvi, M.; Wagh, U.V. Hyaluronidase and collagenase inhibitory activities of the herbal formulation Triphala guggulu. J. Biosci., 2007, 32, 755-61.
191. Sumantran, V.N.; Kulkarni, A.; Chandwaskar, R.; Harsulkar, A.; Patwardhan, B.; Chopra, A.; Wagh, U.V. Chondroprotective potential of fruit extracts of Phyllanthus emblica in osteoarthritis. eCAM, 2008, 5, 329-335.
192. Bralley, E.; Greenspan, P.; Hargrove, J.L.; Hartle, D.K. Inhibition of hyaluronidase activity by select sorghum brans. J. Med. Food, 2008, 11, 307-12.
193. Liao, Y.H. Hyaluronan: Pharmaceutical characterization and drug delivery. Drug Deliv., 2005, 12, 327-342.
194. Ji, Y.; Ghosh, K.; Shu, X.Z.; Li, B.; Sokolov, J.C.; Prestwich, G.D.; Clark, R.A.F.; Rafailovich, M.H. Electrospun three-dimensional hyaluronic acid nanofibrous scaffolds. Biomaterials, 2006, 27, 3782-3792.
195. Ramamurthi, A.; Vesely, I. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials, 2005, 26, 999-1010.
196. Palasz, A.T.; Rodriguez-Martinez, H.; Beltran-Brena, P.; Perez-Garnelo, S.; Martinez, M.F.; Gutierrez-Adan, A.; De la Fuente, J. Effects of hyaluronan, BSA, and serum on bovine embryo in vitro development, ultrastructure, and gene expression patterns. Mol. Reprod. Dev., 2006, 73, 5345-5355.
197. Allison, D.D.; Grande-Allen K.J. Hyaluronan: A powerful tissue-engineering tool. Tissue Eng., 2006, 12, 2131-2140.
198. Hahn, S.K.; Kim, J.S.; Shimobouji, T. Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin. J. Biomed. Mater. Res. A, 2007, 80(4), 916-924.